ANDE
The Andersons, Inc.
ANDE has lower modeled downside risk, despite its lower overall score.
CELH
Celsius Holdings, Inc.
CELH has the edge over ANDE overall, supported by stronger fundamentals and stronger modeled upside.
ANDE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Under pressure | |
| Stable |
ANDE's profitability is currently healthy, and its revenue and balance sheet are stable, but its cash flow is under pressure.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
ANDE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 8.7x | $54.87 | — |
| Current | 9.2x | $54.87 | — |
| Cheap | 11x | $68.18 | +24% |
| Fair | 15x | $87.42 | +59% |
| Expensive | 24x | $144 | +163% |
Historical ranges are pointers, not guarantees.
ANDE has the edge over CELH in the historical PE scenario, which offers more potential upside but is not a forecast.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
ANDE Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect ANDE's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over ANDE on the outlook, with more favorable revenue expectations.
ANDE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.34 | +6.7% |
| Q3 2026 | $5.94 | +178% |
| Q2 2026 | $5.17 | +120% |
| Q1 2026 | $3.75 | +18% |
| Q4 2025 | $2.79 | -16% |
| Q3 2025 | $2.14 | -39% |
| Q2 2025 | $2.35 | -21% |
| Q1 2025 | $3.17 | -10% |
| Q4 2024 | $3.32 | +13% |
ANDE has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
ANDE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.8B | +5.8% |
| Q2 2026 | $3.1B | -1.2% |
| Q1 2026 | $2.6B | -1.2% |
| Q4 2025 | $2.5B | -19% |
| Q3 2025 | $2.7B | +2.2% |
| Q2 2025 | $3.1B | +12% |
| Q1 2025 | $2.7B | -2.2% |
| Q4 2024 | $3.1B | -2.8% |
ANDE's revenue is recovering but still below its 2022 peak: $2.8B last quarter, up 5.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.8% | +0.8 points |
| Q2 2026 | 2.2% | +1.4 points |
| Q1 2026 | 1.3% | +1.2 points |
| Q4 2025 | 3.5% | +1.3 points |
| Q3 2025 | 1% | -1.4 points |
| Q2 2025 | 0.8% | -1.3 points |
| Q1 2025 | 0.1% | -0.4 points |
| Q4 2024 | 2.1% | -0.7 points |
ANDE's operating margin was 1.8% last quarter, up 0.8 points from the same quarter a year ago.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over ANDE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over ANDE on profitability, with a higher operating margin.
ANDE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$183.8M | -210% |
| Q2 2026 | $412.4M | +65% |
| Q1 2026 | -$445.4M | -$48.8M |
| Q4 2025 | -$77.1M | -136% |
| Q3 2025 | $167M | +$207M |
| Q2 2025 | $250.5M | -9.2% |
| Q1 2025 | -$396.6M | -$130.2M |
| Q4 2024 | $212.9M | +1.9% |
ANDE's free cash flow was −$294M over the past year, against $234M the year before.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over ANDE on cash generation, producing positive trailing cash flow while its opponent burns cash.
ANDE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -63K shares |
| 1 year | +0.1% | +25K shares |
| 3 years | -0.2% | -61K shares |
| 5 years | +1.7% | +575K shares |
| Available history | +3.4% | +1.1M shares |
ANDE has 34M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $14.5M |
| Q4 2025 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | $76,000 |
| Q1 2023 | $1.7M |
| Q4 2022 | $6M |
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over ANDE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
ANDE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.7x | Moderate |
| Q2 2026 | 2.4x | Moderate |
| Q1 2026 | 4.1x | High |
| Q4 2025 | 1.9x | Healthy |
| Q3 2025 | 2.7x | Moderate |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | 2.1x | Moderate |
| Q4 2024 | 0.3x | Very low |
ANDE's net debt is about 2.7 years of its operating earnings (EBITDA), about the same as a year ago.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over ANDE on leverage, with a lower net debt burden relative to earnings.
ANDE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.3 | Neutral |
| Stochastic | 9.2 | Oversold |
ANDE's weekly RSI is 34 (neutral) and its Stochastic is 9 (oversold).
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
ANDE PE vs Consumer Defensive Sector
| Metric | ANDE | Sector median | Relative |
|---|---|---|---|
| PE | 9.2x | 19x | 53% below |
| PE % | 7 | 18 | 11 pts below |
ANDE has the edge over CELH on valuation relative to its sector.
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
ANDE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.8 | 13% below |
| 20 week MA | $67.1 | 18% below |
| 50 week MA | $66.6 | 18% below |
| 100 week MA | $53.6 | 2.4% above |
| 200 week MA | $51.3 | 7.1% above |
ANDE has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 7.1% above its 200-week average.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
ANDE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $24.7 | $23.8 | -3.8% |
| 2021 | $23.8 | $38.1 | +60% |
| 2022 | $38.1 | $36.0 | -5.5% |
| 2023 | $36.0 | $57.5 | +60% |
| 2024 | $57.5 | $40.1 | -30% |
| 2025 | $40.1 | $53.3 | +33% |
| 2026 YTD | $53.3 | $54.9 | +2.9% |
ANDE has the edge over CELH on returns for 2026, with the stronger performance.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.